Review



rhoa elisa assay kit  (Cytoskeleton Inc)


Bioz Verified Symbol Cytoskeleton Inc is a verified supplier
Bioz Manufacturer Symbol Cytoskeleton Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cytoskeleton Inc rhoa elisa assay kit
    Rhoa Elisa Assay Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 82 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+elisa+kit/Total+RhoA+ELISA/pm41845043-408-17-21
    Average 94 stars, based on 82 article reviews
    rhoa elisa assay kit - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    Activity Assay:

    Article Title: ARHGEF17 Deficiency Induces Endothelial Dysfunction and Intracranial Aneurysm Formation via RhoA/ROCK2/MLC Signaling Pathway
    Article Snippet: .. RhoA activity in HUVECs was detected by G-LISA (BK124, Cytoskeleton, US) according to the manufacturer’s instructions, and normalized to total RhoA levels, which were measured using the Total RhoA ELISA kit (BK150, Cytoskeleton) according to the manufacturer’s instructions. ..

    Enzyme-linked Immunosorbent Assay:

    Article Title: ARHGEF17 Deficiency Induces Endothelial Dysfunction and Intracranial Aneurysm Formation via RhoA/ROCK2/MLC Signaling Pathway
    Article Snippet: .. RhoA activity in HUVECs was detected by G-LISA (BK124, Cytoskeleton, US) according to the manufacturer’s instructions, and normalized to total RhoA levels, which were measured using the Total RhoA ELISA kit (BK150, Cytoskeleton) according to the manufacturer’s instructions. ..

    Article Title: Phenotypic pleiotropy of missense variants in human B cell confinement receptor P2RY8.
    Article Snippet: Protein quantified using Qubit (Thermo Fisher Scientific) On day ELISA performed, sample thawed on ice, diluted to 2 mg mL− 1 total protein concentration with lysis buffer based on prefreeze quantification, and each sample assayed as technical duplicates for active RhoA using RhoA G-LISA GTPase Activation Assay Kit (Cytoskeleton) and for total RhoA using Total RhoA ELISA Kit (Cytoskeleton) per kit protocols. .. Protein quantified using Qubit (Thermo Fisher Scientific) On day ELISA performed, sample thawed on ice, diluted to 2 mg mL− 1 total protein concentration with lysis buffer based on prefreeze quantification, and each sample assayed as technical duplicates for active RhoA using RhoA G-LISA GTPase Activation Assay Kit (Cytoskeleton) and for total RhoA using Total RhoA ELISA Kit (Cytoskeleton) per kit protocols. ..

    Article Title: Phenotypic pleiotropy of missense variants in human B cell confinement receptor P2RY8
    Article Snippet: .. Protein quantified using Qubit (Thermo Fisher Scientific) On day ELISA performed, sample thawed on ice, diluted to 2 mg mL −1 total protein concentration with lysis buffer based on pre-freeze quantification, and each sample assayed as technical duplicates for active RhoA using RhoA G-LISA GTPase Activation Assay Kit (Cytoskeleton) and for total RhoA using Total RhoA ELISA Kit (Cytoskeleton) per kit protocols. ..

    Article Title: Small molecule modulation of the p75 neurotrophin receptor promotes dendritic spine resilience to pathogenic tau species and reduces their accumulation
    Article Snippet: .. For analysis of RhoA activation, a G-LISA RhoA Activation Assay Biochem kit and a total RhoA ELISA kit (Cytoskeleton, Inc. Denver, CO) were used according to the manufacturer’s instructions. .. Briefly, protein concentrations in hippocampal protein lysates were measured using the Precision Red Advanced Protein Assay (Cytoskeleton, Inc) and normalized to the same concentration across all samples.

    Article Title: The molecular mechanism of ambrosin-induced cytotoxicity of human breast cancer and bladder cancer cells
    Article Snippet: RhoC activation assay kit (ab211166) (Abcam, Cambridge) was used, which provides Rhotekin RBD Agarose beads to selectively isolate and pull down the active form of Rho from purified samples. .. Endogenous active and total RhoC GTPase was determined using a G-LISA RhoA activation assay kit and a Total RhoA ELISA kit (Cytoskeleton, Inc.) with previously described modifications ( ) ( https://onlinelibrary.wiley.com/doi/10.1002/ijc.25655 ). .. RhoC activation assay kit (ab211166) (Abcam, Cambridge) was used, which provides Rhotekin RBD Agarose beads to selectively isolate and pull down the active form of Rho from purified samples.

    Article Title: Pediococcus pentosaceus LAB6- and Lactiplantibacillus plantarum LAB12-Derived Cell Free Supernatant Inhibited RhoA Activation and Reduced Amyloid-Β In Vitro.
    Article Snippet: Alzheimer’s disease (AD) is characterized by aggregation of amyloid beta (Aβ) plaque.. RhoA may serve as a potential target for prevention against AD given its role in the amyloidogenic pathway.. The recent emergence of the gut-brain axis has linked lactic acid bacteria (LAB) to neuroprotection against AD.

    Article Title: Phenotypic pleiotropy of missense variants in human B cell confinement receptor P2RY8
    Article Snippet: RhoA G-LISA GTPase Activation Assay Kit (colorimetric) , Cytoskeleton , Cat# BK124. .. Total RhoA ELISA Kit , Cytoskeleton , Cat# BK150. .. ExpiFectamine 293 Transfection Kit , Thermo Fisher Scientific , Cat# A14525.

    Article Title: Small molecule modulation of the p75 neurotrophin receptor promotes dendritic spine resilience to pathogenic tau species and reduces their accumulation.
    Article Snippet: .. ` G-LISA RhoA activation assays: For analysis of RhoA activation, a G-LISA RhoA Activation Assay Biochem kit and a total RhoA ELISA kit (Cytoskeleton, Inc. Denver, CO) were used according to the manufacturer’s instructions. .. Briefly, protein concentrations in hippocampal protein lysates were measured using the Precision Red Advanced Protein Assay (Cytoskeleton, Inc) and normalized to the same concentration across all samples.

    Protein Concentration:

    Article Title: Phenotypic pleiotropy of missense variants in human B cell confinement receptor P2RY8.
    Article Snippet: Protein quantified using Qubit (Thermo Fisher Scientific) On day ELISA performed, sample thawed on ice, diluted to 2 mg mL− 1 total protein concentration with lysis buffer based on prefreeze quantification, and each sample assayed as technical duplicates for active RhoA using RhoA G-LISA GTPase Activation Assay Kit (Cytoskeleton) and for total RhoA using Total RhoA ELISA Kit (Cytoskeleton) per kit protocols. .. Protein quantified using Qubit (Thermo Fisher Scientific) On day ELISA performed, sample thawed on ice, diluted to 2 mg mL− 1 total protein concentration with lysis buffer based on prefreeze quantification, and each sample assayed as technical duplicates for active RhoA using RhoA G-LISA GTPase Activation Assay Kit (Cytoskeleton) and for total RhoA using Total RhoA ELISA Kit (Cytoskeleton) per kit protocols. ..

    Article Title: Phenotypic pleiotropy of missense variants in human B cell confinement receptor P2RY8
    Article Snippet: .. Protein quantified using Qubit (Thermo Fisher Scientific) On day ELISA performed, sample thawed on ice, diluted to 2 mg mL −1 total protein concentration with lysis buffer based on pre-freeze quantification, and each sample assayed as technical duplicates for active RhoA using RhoA G-LISA GTPase Activation Assay Kit (Cytoskeleton) and for total RhoA using Total RhoA ELISA Kit (Cytoskeleton) per kit protocols. ..

    Lysis:

    Article Title: Phenotypic pleiotropy of missense variants in human B cell confinement receptor P2RY8.
    Article Snippet: Protein quantified using Qubit (Thermo Fisher Scientific) On day ELISA performed, sample thawed on ice, diluted to 2 mg mL− 1 total protein concentration with lysis buffer based on prefreeze quantification, and each sample assayed as technical duplicates for active RhoA using RhoA G-LISA GTPase Activation Assay Kit (Cytoskeleton) and for total RhoA using Total RhoA ELISA Kit (Cytoskeleton) per kit protocols. .. Protein quantified using Qubit (Thermo Fisher Scientific) On day ELISA performed, sample thawed on ice, diluted to 2 mg mL− 1 total protein concentration with lysis buffer based on prefreeze quantification, and each sample assayed as technical duplicates for active RhoA using RhoA G-LISA GTPase Activation Assay Kit (Cytoskeleton) and for total RhoA using Total RhoA ELISA Kit (Cytoskeleton) per kit protocols. ..

    Article Title: Phenotypic pleiotropy of missense variants in human B cell confinement receptor P2RY8
    Article Snippet: .. Protein quantified using Qubit (Thermo Fisher Scientific) On day ELISA performed, sample thawed on ice, diluted to 2 mg mL −1 total protein concentration with lysis buffer based on pre-freeze quantification, and each sample assayed as technical duplicates for active RhoA using RhoA G-LISA GTPase Activation Assay Kit (Cytoskeleton) and for total RhoA using Total RhoA ELISA Kit (Cytoskeleton) per kit protocols. ..

    Activation Assay:

    Article Title: Phenotypic pleiotropy of missense variants in human B cell confinement receptor P2RY8.
    Article Snippet: Protein quantified using Qubit (Thermo Fisher Scientific) On day ELISA performed, sample thawed on ice, diluted to 2 mg mL− 1 total protein concentration with lysis buffer based on prefreeze quantification, and each sample assayed as technical duplicates for active RhoA using RhoA G-LISA GTPase Activation Assay Kit (Cytoskeleton) and for total RhoA using Total RhoA ELISA Kit (Cytoskeleton) per kit protocols. .. Protein quantified using Qubit (Thermo Fisher Scientific) On day ELISA performed, sample thawed on ice, diluted to 2 mg mL− 1 total protein concentration with lysis buffer based on prefreeze quantification, and each sample assayed as technical duplicates for active RhoA using RhoA G-LISA GTPase Activation Assay Kit (Cytoskeleton) and for total RhoA using Total RhoA ELISA Kit (Cytoskeleton) per kit protocols. ..

    Article Title: Phenotypic pleiotropy of missense variants in human B cell confinement receptor P2RY8
    Article Snippet: .. Protein quantified using Qubit (Thermo Fisher Scientific) On day ELISA performed, sample thawed on ice, diluted to 2 mg mL −1 total protein concentration with lysis buffer based on pre-freeze quantification, and each sample assayed as technical duplicates for active RhoA using RhoA G-LISA GTPase Activation Assay Kit (Cytoskeleton) and for total RhoA using Total RhoA ELISA Kit (Cytoskeleton) per kit protocols. ..

    Article Title: Small molecule modulation of the p75 neurotrophin receptor promotes dendritic spine resilience to pathogenic tau species and reduces their accumulation
    Article Snippet: .. For analysis of RhoA activation, a G-LISA RhoA Activation Assay Biochem kit and a total RhoA ELISA kit (Cytoskeleton, Inc. Denver, CO) were used according to the manufacturer’s instructions. .. Briefly, protein concentrations in hippocampal protein lysates were measured using the Precision Red Advanced Protein Assay (Cytoskeleton, Inc) and normalized to the same concentration across all samples.

    Article Title: The molecular mechanism of ambrosin-induced cytotoxicity of human breast cancer and bladder cancer cells
    Article Snippet: RhoC activation assay kit (ab211166) (Abcam, Cambridge) was used, which provides Rhotekin RBD Agarose beads to selectively isolate and pull down the active form of Rho from purified samples. .. Endogenous active and total RhoC GTPase was determined using a G-LISA RhoA activation assay kit and a Total RhoA ELISA kit (Cytoskeleton, Inc.) with previously described modifications ( ) ( https://onlinelibrary.wiley.com/doi/10.1002/ijc.25655 ). .. RhoC activation assay kit (ab211166) (Abcam, Cambridge) was used, which provides Rhotekin RBD Agarose beads to selectively isolate and pull down the active form of Rho from purified samples.

    Article Title: Small molecule modulation of the p75 neurotrophin receptor promotes dendritic spine resilience to pathogenic tau species and reduces their accumulation.
    Article Snippet: .. ` G-LISA RhoA activation assays: For analysis of RhoA activation, a G-LISA RhoA Activation Assay Biochem kit and a total RhoA ELISA kit (Cytoskeleton, Inc. Denver, CO) were used according to the manufacturer’s instructions. .. Briefly, protein concentrations in hippocampal protein lysates were measured using the Precision Red Advanced Protein Assay (Cytoskeleton, Inc) and normalized to the same concentration across all samples.



    Similar Products

    94
    Cytoskeleton Inc rhoa elisa assay kit
    Rhoa Elisa Assay Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+elisa+kit/Total+RhoA+ELISA/pm41845043-408-17-21
    Average 94 stars, based on 1 article reviews
    rhoa elisa assay kit - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Cytoskeleton Inc rhoa elisa kit
    p75 NTR modulation mitigates oTau-induced alterations in PKC, <t>RhoA,</t> LIMK1, and cofilin signaling. A – I Hippocampal neurons at 21 days in vitro were collected one hour after the indicated treatments. A – E , G Neurons were treated with culture medium (CM) or recombinant oTau ± concomitant LM11A-31 (C31, 100 nM). F , H , I Neurons were treated with CM or hippocampal S1p fractions (designed to capture oTau) from Wt or PS19 mice ± LM11A-31 (100 nM) concomitantly added to the cultured neurons. A Representative Western blot images are shown ( B – D , G – I ). Western blots were quantitated as ratios of phospho (p)-protein to total protein or actin; or for calpain activity, as a ratio of cleaved (~ 145 kDa) to uncleaved (~ 250 kDa) α-fodrin. All values were subsequently normalized to the CM condition. E , F Activation of RhoA was measured using a G-LISA assay kit. Statistical significance was assessed in E , F using Kruskal–Wallis testing with Dunn’s multiple comparisons test, for E, H = 17.36, p = 0.0002; for F, H = 21.18, p = 0.0003, n = 8 protein preparations from 8 independent experiments; in B – D and G using ordinary one-way ANOVA with Dunnett’s multiple comparisons testing (JNK, F (2, 33) = 0.08885, p = 0.9152) and Kruskal–Wallis testing with Dunn’s multiple comparisons [(calpain (H = 0.5687, p = 0.7458), PKC (H = 19.76, p < 0.0001), and cofilin (H = 14.49, p = 0.0007)] , n = 13 individual protein preparations for each condition from 13 independent experiments; and in H , using Kruskal–Wallis with Dunn’s multiple comparisons test (H = 14.99, p = 0.0018), n = 8 individual protein preparations for each condition from 8 independent experiments; in I using Kruskal–Wallis testing with Dunn’s multiple comparisons test (H = 19.52, p = 0.0006), n = 10 individual protein preparations for each condition from 10 independent experiments. J , K Hippocampal neurons at 20 days in vitro were treated with CM or the slingshot inhibitor (SSHi) D3 (5 µM), or the LIMK inhibitor (LIMKi) BMS-3 (5 nM) ± oTau and/or ± C31 (100 nM). Neurons were fixed 24 h following treatment. Quantitation of dendritic spine density (number of spines per length of dendrite segment) displayed as a J batch-corrected spines/µm and K cumulative frequency distribution. Bars in B – I represent mean ± SE. Bars in J show estimated marginal mean ± SE. Statistical significance was determined using a linear model (for J , INT Spine density ~ group + batch, F(13, 166) = 14.279, p < 2e−16) followed by pairwise comparison of estimated marginal means (Bonferroni p-adj shown in figure), or in K using Kolmogorov–Smirnov testing of indicated comparisons. J , K n = 15 neurons per condition from 3 independent experiments (n = 3–6 neurons per condition per experiment). INT–inverse normal transformation
    Rhoa Elisa Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+elisa+kit/Total+RhoA+ELISA/pmc13077901-105-15-18
    Average 94 stars, based on 1 article reviews
    rhoa elisa kit - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Cytoskeleton Inc rhoa g elisa activation assay kit
    p75 NTR modulation mitigates oTau-induced alterations in PKC, <t>RhoA,</t> LIMK1, and cofilin signaling. A – I Hippocampal neurons at 21 days in vitro were collected one hour after the indicated treatments. A – E , G Neurons were treated with culture medium (CM) or recombinant oTau ± concomitant LM11A-31 (C31, 100 nM). F , H , I Neurons were treated with CM or hippocampal S1p fractions (designed to capture oTau) from Wt or PS19 mice ± LM11A-31 (100 nM) concomitantly added to the cultured neurons. A Representative Western blot images are shown ( B – D , G – I ). Western blots were quantitated as ratios of phospho (p)-protein to total protein or actin; or for calpain activity, as a ratio of cleaved (~ 145 kDa) to uncleaved (~ 250 kDa) α-fodrin. All values were subsequently normalized to the CM condition. E , F Activation of RhoA was measured using a G-LISA assay kit. Statistical significance was assessed in E , F using Kruskal–Wallis testing with Dunn’s multiple comparisons test, for E, H = 17.36, p = 0.0002; for F, H = 21.18, p = 0.0003, n = 8 protein preparations from 8 independent experiments; in B – D and G using ordinary one-way ANOVA with Dunnett’s multiple comparisons testing (JNK, F (2, 33) = 0.08885, p = 0.9152) and Kruskal–Wallis testing with Dunn’s multiple comparisons [(calpain (H = 0.5687, p = 0.7458), PKC (H = 19.76, p < 0.0001), and cofilin (H = 14.49, p = 0.0007)] , n = 13 individual protein preparations for each condition from 13 independent experiments; and in H , using Kruskal–Wallis with Dunn’s multiple comparisons test (H = 14.99, p = 0.0018), n = 8 individual protein preparations for each condition from 8 independent experiments; in I using Kruskal–Wallis testing with Dunn’s multiple comparisons test (H = 19.52, p = 0.0006), n = 10 individual protein preparations for each condition from 10 independent experiments. J , K Hippocampal neurons at 20 days in vitro were treated with CM or the slingshot inhibitor (SSHi) D3 (5 µM), or the LIMK inhibitor (LIMKi) BMS-3 (5 nM) ± oTau and/or ± C31 (100 nM). Neurons were fixed 24 h following treatment. Quantitation of dendritic spine density (number of spines per length of dendrite segment) displayed as a J batch-corrected spines/µm and K cumulative frequency distribution. Bars in B – I represent mean ± SE. Bars in J show estimated marginal mean ± SE. Statistical significance was determined using a linear model (for J , INT Spine density ~ group + batch, F(13, 166) = 14.279, p < 2e−16) followed by pairwise comparison of estimated marginal means (Bonferroni p-adj shown in figure), or in K using Kolmogorov–Smirnov testing of indicated comparisons. J , K n = 15 neurons per condition from 3 independent experiments (n = 3–6 neurons per condition per experiment). INT–inverse normal transformation
    Rhoa G Elisa Activation Assay Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+elisa+kit/Total+RhoA+ELISA/pm41538962-135-9-14
    Average 94 stars, based on 1 article reviews
    rhoa g elisa activation assay kit - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Cytoskeleton Inc rhoa
    p75 NTR modulation mitigates oTau-induced alterations in PKC, <t>RhoA,</t> LIMK1, and cofilin signaling. A – I Hippocampal neurons at 21 days in vitro were collected one hour after the indicated treatments. A – E , G Neurons were treated with culture medium (CM) or recombinant oTau ± concomitant LM11A-31 (C31, 100 nM). F , H , I Neurons were treated with CM or hippocampal S1p fractions (designed to capture oTau) from Wt or PS19 mice ± LM11A-31 (100 nM) concomitantly added to the cultured neurons. A Representative Western blot images are shown ( B – D , G – I ). Western blots were quantitated as ratios of phospho (p)-protein to total protein or actin; or for calpain activity, as a ratio of cleaved (~ 145 kDa) to uncleaved (~ 250 kDa) α-fodrin. All values were subsequently normalized to the CM condition. E , F Activation of RhoA was measured using a G-LISA assay kit. Statistical significance was assessed in E , F using Kruskal–Wallis testing with Dunn’s multiple comparisons test, for E, H = 17.36, p = 0.0002; for F, H = 21.18, p = 0.0003, n = 8 protein preparations from 8 independent experiments; in B – D and G using ordinary one-way ANOVA with Dunnett’s multiple comparisons testing (JNK, F (2, 33) = 0.08885, p = 0.9152) and Kruskal–Wallis testing with Dunn’s multiple comparisons [(calpain (H = 0.5687, p = 0.7458), PKC (H = 19.76, p < 0.0001), and cofilin (H = 14.49, p = 0.0007)] , n = 13 individual protein preparations for each condition from 13 independent experiments; and in H , using Kruskal–Wallis with Dunn’s multiple comparisons test (H = 14.99, p = 0.0018), n = 8 individual protein preparations for each condition from 8 independent experiments; in I using Kruskal–Wallis testing with Dunn’s multiple comparisons test (H = 19.52, p = 0.0006), n = 10 individual protein preparations for each condition from 10 independent experiments. J , K Hippocampal neurons at 20 days in vitro were treated with CM or the slingshot inhibitor (SSHi) D3 (5 µM), or the LIMK inhibitor (LIMKi) BMS-3 (5 nM) ± oTau and/or ± C31 (100 nM). Neurons were fixed 24 h following treatment. Quantitation of dendritic spine density (number of spines per length of dendrite segment) displayed as a J batch-corrected spines/µm and K cumulative frequency distribution. Bars in B – I represent mean ± SE. Bars in J show estimated marginal mean ± SE. Statistical significance was determined using a linear model (for J , INT Spine density ~ group + batch, F(13, 166) = 14.279, p < 2e−16) followed by pairwise comparison of estimated marginal means (Bonferroni p-adj shown in figure), or in K using Kolmogorov–Smirnov testing of indicated comparisons. J , K n = 15 neurons per condition from 3 independent experiments (n = 3–6 neurons per condition per experiment). INT–inverse normal transformation
    Rhoa, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+elisa+kit/Total+RhoA+ELISA/pmc12648108-704-52-58
    Average 94 stars, based on 1 article reviews
    rhoa - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Cytoskeleton Inc bk124 total rhoa elisa kit cytoskeleton
    p75 NTR modulation mitigates oTau-induced alterations in PKC, <t>RhoA,</t> LIMK1, and cofilin signaling. A – I Hippocampal neurons at 21 days in vitro were collected one hour after the indicated treatments. A – E , G Neurons were treated with culture medium (CM) or recombinant oTau ± concomitant LM11A-31 (C31, 100 nM). F , H , I Neurons were treated with CM or hippocampal S1p fractions (designed to capture oTau) from Wt or PS19 mice ± LM11A-31 (100 nM) concomitantly added to the cultured neurons. A Representative Western blot images are shown ( B – D , G – I ). Western blots were quantitated as ratios of phospho (p)-protein to total protein or actin; or for calpain activity, as a ratio of cleaved (~ 145 kDa) to uncleaved (~ 250 kDa) α-fodrin. All values were subsequently normalized to the CM condition. E , F Activation of RhoA was measured using a G-LISA assay kit. Statistical significance was assessed in E , F using Kruskal–Wallis testing with Dunn’s multiple comparisons test, for E, H = 17.36, p = 0.0002; for F, H = 21.18, p = 0.0003, n = 8 protein preparations from 8 independent experiments; in B – D and G using ordinary one-way ANOVA with Dunnett’s multiple comparisons testing (JNK, F (2, 33) = 0.08885, p = 0.9152) and Kruskal–Wallis testing with Dunn’s multiple comparisons [(calpain (H = 0.5687, p = 0.7458), PKC (H = 19.76, p < 0.0001), and cofilin (H = 14.49, p = 0.0007)] , n = 13 individual protein preparations for each condition from 13 independent experiments; and in H , using Kruskal–Wallis with Dunn’s multiple comparisons test (H = 14.99, p = 0.0018), n = 8 individual protein preparations for each condition from 8 independent experiments; in I using Kruskal–Wallis testing with Dunn’s multiple comparisons test (H = 19.52, p = 0.0006), n = 10 individual protein preparations for each condition from 10 independent experiments. J , K Hippocampal neurons at 20 days in vitro were treated with CM or the slingshot inhibitor (SSHi) D3 (5 µM), or the LIMK inhibitor (LIMKi) BMS-3 (5 nM) ± oTau and/or ± C31 (100 nM). Neurons were fixed 24 h following treatment. Quantitation of dendritic spine density (number of spines per length of dendrite segment) displayed as a J batch-corrected spines/µm and K cumulative frequency distribution. Bars in B – I represent mean ± SE. Bars in J show estimated marginal mean ± SE. Statistical significance was determined using a linear model (for J , INT Spine density ~ group + batch, F(13, 166) = 14.279, p < 2e−16) followed by pairwise comparison of estimated marginal means (Bonferroni p-adj shown in figure), or in K using Kolmogorov–Smirnov testing of indicated comparisons. J , K n = 15 neurons per condition from 3 independent experiments (n = 3–6 neurons per condition per experiment). INT–inverse normal transformation
    Bk124 Total Rhoa Elisa Kit Cytoskeleton, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rhoa+elisa+kit/Total+RhoA+ELISA/pm40930105-297-99-104
    Average 94 stars, based on 1 article reviews
    bk124 total rhoa elisa kit cytoskeleton - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    p75 NTR modulation mitigates oTau-induced alterations in PKC, RhoA, LIMK1, and cofilin signaling. A – I Hippocampal neurons at 21 days in vitro were collected one hour after the indicated treatments. A – E , G Neurons were treated with culture medium (CM) or recombinant oTau ± concomitant LM11A-31 (C31, 100 nM). F , H , I Neurons were treated with CM or hippocampal S1p fractions (designed to capture oTau) from Wt or PS19 mice ± LM11A-31 (100 nM) concomitantly added to the cultured neurons. A Representative Western blot images are shown ( B – D , G – I ). Western blots were quantitated as ratios of phospho (p)-protein to total protein or actin; or for calpain activity, as a ratio of cleaved (~ 145 kDa) to uncleaved (~ 250 kDa) α-fodrin. All values were subsequently normalized to the CM condition. E , F Activation of RhoA was measured using a G-LISA assay kit. Statistical significance was assessed in E , F using Kruskal–Wallis testing with Dunn’s multiple comparisons test, for E, H = 17.36, p = 0.0002; for F, H = 21.18, p = 0.0003, n = 8 protein preparations from 8 independent experiments; in B – D and G using ordinary one-way ANOVA with Dunnett’s multiple comparisons testing (JNK, F (2, 33) = 0.08885, p = 0.9152) and Kruskal–Wallis testing with Dunn’s multiple comparisons [(calpain (H = 0.5687, p = 0.7458), PKC (H = 19.76, p < 0.0001), and cofilin (H = 14.49, p = 0.0007)] , n = 13 individual protein preparations for each condition from 13 independent experiments; and in H , using Kruskal–Wallis with Dunn’s multiple comparisons test (H = 14.99, p = 0.0018), n = 8 individual protein preparations for each condition from 8 independent experiments; in I using Kruskal–Wallis testing with Dunn’s multiple comparisons test (H = 19.52, p = 0.0006), n = 10 individual protein preparations for each condition from 10 independent experiments. J , K Hippocampal neurons at 20 days in vitro were treated with CM or the slingshot inhibitor (SSHi) D3 (5 µM), or the LIMK inhibitor (LIMKi) BMS-3 (5 nM) ± oTau and/or ± C31 (100 nM). Neurons were fixed 24 h following treatment. Quantitation of dendritic spine density (number of spines per length of dendrite segment) displayed as a J batch-corrected spines/µm and K cumulative frequency distribution. Bars in B – I represent mean ± SE. Bars in J show estimated marginal mean ± SE. Statistical significance was determined using a linear model (for J , INT Spine density ~ group + batch, F(13, 166) = 14.279, p < 2e−16) followed by pairwise comparison of estimated marginal means (Bonferroni p-adj shown in figure), or in K using Kolmogorov–Smirnov testing of indicated comparisons. J , K n = 15 neurons per condition from 3 independent experiments (n = 3–6 neurons per condition per experiment). INT–inverse normal transformation

    Journal: Acta Neuropathologica Communications

    Article Title: Small molecule modulation of the p75 neurotrophin receptor promotes dendritic spine resilience to pathogenic tau species and reduces their accumulation

    doi: 10.1186/s40478-026-02263-5

    Figure Lengend Snippet: p75 NTR modulation mitigates oTau-induced alterations in PKC, RhoA, LIMK1, and cofilin signaling. A – I Hippocampal neurons at 21 days in vitro were collected one hour after the indicated treatments. A – E , G Neurons were treated with culture medium (CM) or recombinant oTau ± concomitant LM11A-31 (C31, 100 nM). F , H , I Neurons were treated with CM or hippocampal S1p fractions (designed to capture oTau) from Wt or PS19 mice ± LM11A-31 (100 nM) concomitantly added to the cultured neurons. A Representative Western blot images are shown ( B – D , G – I ). Western blots were quantitated as ratios of phospho (p)-protein to total protein or actin; or for calpain activity, as a ratio of cleaved (~ 145 kDa) to uncleaved (~ 250 kDa) α-fodrin. All values were subsequently normalized to the CM condition. E , F Activation of RhoA was measured using a G-LISA assay kit. Statistical significance was assessed in E , F using Kruskal–Wallis testing with Dunn’s multiple comparisons test, for E, H = 17.36, p = 0.0002; for F, H = 21.18, p = 0.0003, n = 8 protein preparations from 8 independent experiments; in B – D and G using ordinary one-way ANOVA with Dunnett’s multiple comparisons testing (JNK, F (2, 33) = 0.08885, p = 0.9152) and Kruskal–Wallis testing with Dunn’s multiple comparisons [(calpain (H = 0.5687, p = 0.7458), PKC (H = 19.76, p < 0.0001), and cofilin (H = 14.49, p = 0.0007)] , n = 13 individual protein preparations for each condition from 13 independent experiments; and in H , using Kruskal–Wallis with Dunn’s multiple comparisons test (H = 14.99, p = 0.0018), n = 8 individual protein preparations for each condition from 8 independent experiments; in I using Kruskal–Wallis testing with Dunn’s multiple comparisons test (H = 19.52, p = 0.0006), n = 10 individual protein preparations for each condition from 10 independent experiments. J , K Hippocampal neurons at 20 days in vitro were treated with CM or the slingshot inhibitor (SSHi) D3 (5 µM), or the LIMK inhibitor (LIMKi) BMS-3 (5 nM) ± oTau and/or ± C31 (100 nM). Neurons were fixed 24 h following treatment. Quantitation of dendritic spine density (number of spines per length of dendrite segment) displayed as a J batch-corrected spines/µm and K cumulative frequency distribution. Bars in B – I represent mean ± SE. Bars in J show estimated marginal mean ± SE. Statistical significance was determined using a linear model (for J , INT Spine density ~ group + batch, F(13, 166) = 14.279, p < 2e−16) followed by pairwise comparison of estimated marginal means (Bonferroni p-adj shown in figure), or in K using Kolmogorov–Smirnov testing of indicated comparisons. J , K n = 15 neurons per condition from 3 independent experiments (n = 3–6 neurons per condition per experiment). INT–inverse normal transformation

    Article Snippet: For analysis of RhoA activation, a G-LISA RhoA Activation Assay Biochem kit and a total RhoA ELISA kit (Cytoskeleton, Inc. Denver, CO) were used according to the manufacturer’s instructions.

    Techniques: In Vitro, Recombinant, Cell Culture, Western Blot, Activity Assay, Activation Assay, Quantitation Assay, Comparison, Transformation Assay

    Proposed model of effects of p75 NTR modulation on oTau-induced accumulation of pathological tau, spine-related signaling, and dendritic spine loss. A oTau treatment induces tau phosphorylation, tau oligomerization, and excess RhoA activation. oTau treatment reduces PKC and LIMK phosphorylation/activity, and decreases cofilin phosphorylation, contributing to spine and dendrite degeneration. Solid black arrows indicate direct regulation, dashed arrows indicate indirect regulation. Red arrows indicate oTau effects. B LM11A-31 modulation of p75 NTR mitigates oTau-induced tau phosphorylation and oligomerization, and reduces oTau-induced alterations in RhoA-ROCK-LIMK/SSH-cofilin signaling, protecting the neurons against oTau-induced dendritic spine loss. Green arrows indicate LM11A-31 action

    Journal: Acta Neuropathologica Communications

    Article Title: Small molecule modulation of the p75 neurotrophin receptor promotes dendritic spine resilience to pathogenic tau species and reduces their accumulation

    doi: 10.1186/s40478-026-02263-5

    Figure Lengend Snippet: Proposed model of effects of p75 NTR modulation on oTau-induced accumulation of pathological tau, spine-related signaling, and dendritic spine loss. A oTau treatment induces tau phosphorylation, tau oligomerization, and excess RhoA activation. oTau treatment reduces PKC and LIMK phosphorylation/activity, and decreases cofilin phosphorylation, contributing to spine and dendrite degeneration. Solid black arrows indicate direct regulation, dashed arrows indicate indirect regulation. Red arrows indicate oTau effects. B LM11A-31 modulation of p75 NTR mitigates oTau-induced tau phosphorylation and oligomerization, and reduces oTau-induced alterations in RhoA-ROCK-LIMK/SSH-cofilin signaling, protecting the neurons against oTau-induced dendritic spine loss. Green arrows indicate LM11A-31 action

    Article Snippet: For analysis of RhoA activation, a G-LISA RhoA Activation Assay Biochem kit and a total RhoA ELISA kit (Cytoskeleton, Inc. Denver, CO) were used according to the manufacturer’s instructions.

    Techniques: Phospho-proteomics, Activation Assay, Activity Assay